Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-Controlled Dose-Finding Study of JNS019 (Topiramate) in Migraine Patients

NCT01081795 is registered in ClinicalTrials.gov with Janssen Pharmaceutical K.K. as lead sponsor.

NCT NCT01081795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01081795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-Controlled Dose-Finding Study of JNS019 (Topiramate) in Migraine Patients
Lead sponsor
Janssen Pharmaceutical K.K.
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2007
Completion date
January 31, 2009
Enrollment
387 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

migraine